UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 24, 2023

Accession Number:	0001193125-23-102996
Submission Type:	POS AM
CIK: 0001936258 Company Name: NewAmsterdam Pharma Co N.V. File Number: 333-268888